Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis

Kopelman, 2000, Obesity as a medical problem, Nature, 404, 635, 10.1038/35007508 Haslam, 2005, Obesity, Lancet, 366, 1197, 10.1016/S0140-6736(05)67483-1 Hegarty, 2003, The role of intramuscular lipid in insulin resistance, Acta Physiol. Scand., 178, 373, 10.1046/j.1365-201X.2003.01162.x Muoio, 2006, Obesity-related derangements in metabolic regulation, Annu. Rev. Biochem., 75, 367, 10.1146/annurev.biochem.75.103004.142512 Krebs, 2004, Nutrient-induced resistance in human skeletal muscle, Curr. Med. Chem., 11, 901, 10.2174/0929867043455620 Petersen, 2007, The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome, Proc. Natl. Acad. Sci. U. S. A., 104, 12587, 10.1073/pnas.0705408104 Civitarese, 2006, Role of adiponectin in human skeletal muscle biogenesis, Cell Metab., 4, 75, 10.1016/j.cmet.2006.05.002 Rolo, 2006, Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress, Toxicol. Appl. Pharmacol., 212, 167, 10.1016/j.taap.2006.01.003 Kelley, 2002, Dysfunction of mitochondria in human skeletal mucle in type 2 diabetes, Diabetes, 51, 2944, 10.2337/diabetes.51.10.2944 Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet., 34, 267, 10.1038/ng1180 Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. U. S. A., 100, 8466, 10.1073/pnas.1032913100 Heilbronn, 2007, Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects, J. Clin. Endocrinol. Metab., 92, 1467, 10.1210/jc.2006-2210 Bonnard, 2008, Mitochondrial dysfunction results from oxidative stress in skeletal muscle of diet-induced insulin-resistant mice, J. Clin. Invest., 118, 789 Yokota, 2009, Oxidative stress in skeletal muscle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice, Am. J. Physiol. Heart Circ. Physiol., 297, H1069, 10.1152/ajpheart.00267.2009 Reznick, 2006, The role of AMP-activated protein kinase in mitochondrial biogenesis, J. Physiol., 574, 33, 10.1113/jphysiol.2006.109512 Gerhart-Hines, 2007, Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha, EMBO J., 26, 1913, 10.1038/sj.emboj.7601633 Haigis, 2010, Mammalian sirtuins: biological inights and disease relevance, Annu. Rev. Pathol., 5, 253, 10.1146/annurev.pathol.4.110807.092250 Rodgers, 2005, Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1, Nature, 434, 113, 10.1038/nature03354 Baur, 2006, Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 444, 337, 10.1038/nature05354 Lagouge, 2006, Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha, Cell, 127, 1109, 10.1016/j.cell.2006.11.013 Feige, 2008, Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation, Cell Metab., 8, 347, 10.1016/j.cmet.2008.08.017 Jeong, 2009, Berberine suppresses proinflammatory responses through AMPK activation in macrophages, Am. J. Physiol. Endocrinol. Metab., 296, E955, 10.1152/ajpendo.90599.2008 Bova, 1992, On the mechanism of vasodilating action of berberine: possible role of inositiol lipid signaling system, J. Pharmacol. Exp. Ther., 261, 318 Choi, 2008, Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis, Anticancer. Res., 28, 3777 Lee, 2006, Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states, Diabetes, 55, 2256, 10.2337/db06-0006 Brusq, 2006, Inhibition of lipid synthesis through activation of AMP kinase: and additional mechanism for the hypolipidemic effects of berberine, J. Lipid Res., 47, 1281, 10.1194/jlr.M600020-JLR200 Turner, 2008, Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action, Diabetes, 57, 1414, 10.2337/db07-1552 Kim, 2009, Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity, Am. J. Physiol. Endocrinol. Metab., 296, E812, 10.1152/ajpendo.90710.2008 Cheng, 2006, Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK, Biochim. Biophys. Acta, 1760, 1682, 10.1016/j.bbagen.2006.09.007 Xia, 2011, Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis, PLoS One, 6, e16556, 10.1371/journal.pone.0016556 Cantó, 2009, AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity, Nature, 458, 1056, 10.1038/nature07813 Lan, 2008, SIRT1 modulation of the acetylation satus, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation, J. Biol. Chem., 283, 27628, 10.1074/jbc.M805711200 Rossetti, 1997, Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action, J. Biol. Chem., 272, 27758, 10.1074/jbc.272.44.27758 Jones, 2006, Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen, Diabetes, 55, 2294, 10.2337/db06-0304 Koves, 2008, Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance, Cell Metab., 7, 45, 10.1016/j.cmet.2007.10.013 Frezza, 2007, Organelle isolation: functional mitochondria from mouse liver, muscle and culture fibroblasts, Nat. Protoc., 2, 287, 10.1038/nprot.2006.478 Rolo, 2000, Bile acids effect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy, Toxicol. Sci., 57, 177, 10.1093/toxsci/57.1.177 Brautigan, 1978, Mitochondrial cytochrome c: preparation and activity of native and chemically modified cytochromes c, Methods Enzymol., 53, 128, 10.1016/S0076-6879(78)53021-8 Singer, 1994, Determination of the activity of succinate, NADH, choline and glycerophosphate dehydrogenases, Biochim. Biophys. Acta, 1363, 100 Varela, 2008, Indirubin-3′-oxime impairs mitochondrial oxidative phosphorylation and prevents mitochondrial permeability transition induction, Toxicol. Appl. Pharmacol., 233, 179, 10.1016/j.taap.2008.08.005 Rolo, 2003, Mitochondrially mediated synergistic cell killing by bile acids, Biochim. Biophys. Acta, 1637, 127, 10.1016/S0925-4439(02)00224-7 Srere, 1963, The citrate condensing enzyme of pigeon breast muscle and moth flight muscle, Acta Chem. Scand., 17, S129, 10.3891/acta.chem.scand.17s-0129 Ruderman, 2003, Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity, Endocrinology, 144, 166, 10.1210/en.2003-0849 Lowell, 2000, Mitochondrial dysfunction and type 2 diabetes, Science, 307, 384, 10.1126/science.1104343 Han, 2010, Redox regulation of AMP-activated protein kinase, PLoS One, 5, e15420, 10.1371/journal.pone.0015420 Chen, 2010, Berberine inhibits PTP1B activity and mimics insulin action, Biochem. Biophys. Res. Commun., 397, 543, 10.1016/j.bbrc.2010.05.153 Palmeira, 2007, Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis, Toxicol. Appl. Pharmacol., 225, 214, 10.1016/j.taap.2007.07.015 Muoio, 2007, Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease, Appl. Physiol. Nutr. Metab., 32, 874, 10.1139/H07-083 Milne, 2007, Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes, Nature, 450, 712, 10.1038/nature06261 de Kreutzenberg, 2011, Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms, Diabetes, 59, 1006, 10.2337/db09-1187 Wang, 2008, Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity, World J. Gastroenterol., 14, 6004, 10.3748/wjg.14.6004 Lu, 2009, Berberine promotes glucagon-like peptide-1 (7–36) amide secretion in streptozotocin-induced diabetic rats, J. Endocrinol., 200, 159, 10.1677/JOE-08-0419 Zhou, 2009, Protective effect of berberine on beta cells in streptozotocin-and high carbohydrate/high-fat diet-induced diabetic rats, Euro. J. Pharmacol., 606, 262, 10.1016/j.ejphar.2008.12.056 Pereira, 2007, Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions, J. Pharmacol. Exp. Ther., 323, 636, 10.1124/jpet.107.128017 Pereira, 2008, Mechanisms of berberine (natural yello 18)-induced mitochondrial dysfunction: interaction with the adenine nucleotide translocator, Toxicol. Sci., 105, 408, 10.1093/toxsci/kfn131 Scarpulla, 2008, Transcriptional paradigms in mammalian mitochondrial biogenesis and function, Physiol. Rev., 88, 611, 10.1152/physrev.00025.2007 Rasbach, 2010, PGC-1alpha regulates HIF2alpha-dependent switch in skeletal muscle fiber type, Proc. Natl. Acad. Sci. U. S. A., 107, 21866, 10.1073/pnas.1016089107 Lu, 2010, Berberine suppresses neuroinflammatory responses through AMPK-activated protein kinase activation in BV-2 microglia, J. Cell. Biochem., 110, 697, 10.1002/jcb.22580 Cok, 2011, Berberine acutely activates the glucose transport activity of GLUT1, Biochimie, 93, 1187, 10.1016/j.biochi.2011.04.013